Unichem Laboratories’ formulation manufacturing facility at Ghaziabad has received an Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) indicating closure of inspection. The inspection was conducted by USFDA in April 2018.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.
